Purchase Order 75N93022P00952

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Psomagen Inc. for $17,004.00 on April 8, 2024, for library preparation and sequencing services, with ultimate completion by June 7, 2024. Work is performed in Rockville, Maryland. No set-aside was used. The order is priced on a firm fixed-price basis.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Psomagen Inc. for $10,320.00 on September 15, 2022, for RNA extraction, DNA isolation, and library preparation services under the FY26 UDO Initiative. No set-aside was used. Performance occurs in Rockville, Maryland. The order is firm fixed price and carries an ultimate completion date of October 14, 2022.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Psomagen Inc. for $98,010.00 on July 30, 2020, for shotgun metagenomic sequencing analysis. Work is performed in Rockville, Maryland. The order carries a firm fixed price and is scheduled for completion by September 18, 2020. The underlying solicitation was posted July 10, 2020, with a due date of July 24, 2020.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Illumina, Inc. valued at $189,332.08 on July 5, 2022 for a service agreement covering multiple Illumina DNA sequencers. The order is firm fixed-price with no set-aside designation. Performance takes place in Bethesda, Maryland. The purchase order was issued under a solicitation posted June 16, 2022 with a due date of June 27, 2022, and carries an ultimate completion date of July 4, 2023.</p>

This is a $206,250 firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services. The contract is for total RNA sequencing services, with an option to increase the value. The awardee is Psomagen Inc., a for-profit manufacturer of genomics and molecular biology services based in Rockville, Maryland. This contract does not have a set-aside designation. Psomagen is...

The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $9,460 firm fixed-price purchase order to Psomagen Inc. for COVID-19 RNA isolation, DNA generation, and library preparation services under the FY26 Unlisted Data Objective (UDO) Initiative. The contract, awarded on September 20, 2022, with an ultimate completion date of September 18, 2023, was performed at Psomagen's facility in Rockville, Maryland. No set-aside designation was applied to this procurement. Psomagen, a...

The National Institute of Allergy and Infectious Diseases awarded a $17,810 firm fixed price purchase order to Psomagen Inc. on September 13, 2021, with an ultimate completion date of August 4, 2022. This contract action was undertaken to administratively de-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a), in preparation for the September 30, 2026 closing of the period of availability for these fiscal year funds. The work was performed in...

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Illumina, Inc. for sequencing kits valued at $19,072.05, with an award date of April 13, 2021 and completion date of May 12, 2021. Performance occurs in San Diego, California. The order is firm fixed price with no set-aside designation.</p>

This firm fixed-price purchase order awards Psomagen Inc. $422,000 to provide RNA sequencing services to the National Institute on Aging (NIA), part of the National Institutes of Health (NIH), from June 2021 through June 2023. The contract supports NIA research on Alzheimer's disease and related dementias by requiring the contractor to construct sequencing libraries from 20 human samples, perform sequencing on an Illumina NovaSeq 6000 platform, and deliver various data files. No set-aside...

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Genscript USA Inc. for peptide sequencing services on September 5, 2022, with a ceiling value of $23,890.75. No set-aside was used. Work is performed in Piscataway, New Jersey. The order is firm fixed price for FY26 UDO Initiative peptide sequencing services, with an ultimate completion date of October 5, 2022.</p>